欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
文章
报告
图书
公募
私募
资讯
搜 索
上传文档
首页
文章
报告
图书
公募
私募
资讯
金融终端
您的当前位置:
首页
>
研究报告
>
外盘报告
> 预览报告
Proxalutamide expects to deliver differentiated clinical results compared with molnupiravir
报告类型:港股公司研究
页数:5
文件大小:976K
上传时间:2024-09-20
机构:招银国际
作者:Jill Wu Andy Wang
91阅读
0收藏
0下载
下载PDF
所需积分:1
如何获取K积分
下载PDF
下载全文所需积分:1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
{{Creator}}
:
回复
{{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
上传用户
文章
0
报告
0
图书
0
相关报告
Riding on China’s healthy dairy demand
Acquisition of Color life’s assets: execution complexity with Wanda
China Technology Sector:Accessing potential risks of recent power shortage toChina tech supply chain
GZRFPR – Capital commitment is even more positive
Promising clinical data presented at ESMO Conference
Good crisis management to remove impact of power suspension; Solid coal mining equipment order intakes
Waiting for multiple catalysts
每日港股简评
China Banking Sector:Impact of developers’ default is manageable
China’s stagflation fears overblown
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5763523","PageTitle":"Proxalutamide expects to deliver differentiated clinical results compared with molnupiravir-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":40,"Face":"/_files/face/0/3m04pa4a.jpg","UName":"卢学名","UpArts":0,"UpRpts":23759,"UpLbies":37},"Rid":5763523,"IsPdf":false,"IsExist":false,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20211006-招银国际-开拓药业-B-09939.HK-Proxalutamideexpectstodeliverdifferentiatedclinicalresu","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}